In its first major M&A move under new CEO Luke Miels, GSK has reached a definitive agreement to acquire California-based... Read more
Category: Uncategorized
Pfizer exits ViiV Healthcare joint venture in $1.9B stake sale
U.S. pharmaceutical giant Pfizer has agreed to divest its entire interest in ViiV Healthcare, a global specialist in HIV treatment,... Read more
Valneva permanently withdraws Ixchiq vaccine from U.S. market
The French biotech firm Valneva has announced the permanent withdrawal of its chikungunya vaccine, Ixchiq, from the United States. This... Read more
Takeda announces layoffs in U.S. neuroscience unit ahead of patent cliff
Pharmaceutical giant Takeda is implementing a new round of job cuts in the United States as it prepares for the... Read more
GSK accelerates development of subcutaneous cancer therapy through tech licensing
Pharmaceutical giant GSK is undertaking a strategic move to optimize the administration of its flagship immunotherapy through a new technological... Read more
Ministry of Health Strengthens Leadership Across Key Departments
In a move to reinforce its organizational structure and enhance governance efficiency, the Ministry of Health has announced a series... Read more
Nationwide recall of 77 cosmetic products over missing documentation
Pharmaceutical authorities have issued a strict enforcement action against 77 cosmetic items distributed by a Hanoi-based firm. The large-scale recall... Read more
Proposed financial mechanism to support juvenile victims
A new legal framework is being developed to establish a compensation and emergency support system for victims under the age... Read more
Novartis secures FDA breakthrough therapy designation for Sjögren’s disease
Recognition from U.S. regulatory authorities On January 19, 2026, the U.S. Food and Drug Administration (FDA) officially granted "Breakthrough Therapy"... Read more








